Biodexa Pharmaceuticals BDRX
NASDAQ BDRX
$0.39 +0.00 (+0.83%)
As of: Oct 21, 2026 · 11:39 AM EDT

Biodexa Pharmaceuticals (BDRX) Acquisitions (2015)

Updated

Biodexa Pharmaceuticals' Acquisitions was -$3.84 million in the quarter ended Dec 31, 2015.

Analysis

Biodexa Pharmaceuticals (BDRX) Acquisitions (2015) Analysis & Trends

For the year ended Dec 31, 2015, Acquisitions at Biodexa Pharmaceuticals came in at -$3.87 million.

  • In earlier years, Acquisitions was $189,520 in the year ended Dec 31, 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 8.75 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn -17.24 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn -
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn -
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 23.00 Mn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn -
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn -
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 11.21 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn -
10 Biodexa Pharmaceuticals 3,915.67 -23.40 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 -3.84 Mn
API Access

Biodexa Pharmaceuticals Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=BDRX&period=max&api_key=YOUR_API_KEY